Drugs / Iron dextran
Iron dextran
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | IRON DEXTRAN | — | 1957-04-25 | fda.gov ↗ |
Trials 12
1956195719581959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT07110935 | Sep 2018 → Feb 2019 | — | Federal Teaching Hospital Abakaliki | Completed | No outcome recorded |
| Phase 1/2 | NCT03279536 | Nov 2017 → Dec 2018 | iron deficiency anemia | Woman's Health University Hospital, Egypt | Completed | No outcome recorded |
| Phase 24 trials · 1 met primary | ||||||
| Phase 2 | NCT06508827 | May 2025 → Jun 2026 | iron deficiency anemia, melanoma | Indiana University | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT05960227 | Jan 2023 → Sep 2024 | acute kidney injury, iron deficiency anemia | Hospital Civil de Guadalajara | Completed | No outcome recorded |
| Phase 2 | NCT05167734 | Nov 2021 → Mar 2024 | anemia | Mayo Clinic | Completed | Met primary |
| Phase 2 | NCT02038023 | Jul 2013 → Jul 2015 | pregnancy disorder | Auerbach Hematology Oncology Associates P C | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03212781 | Jun → Sep 2016 | anemia | Assiut University | Completed | No outcome recorded |
| Phase 45 trials · 1 met primary | ||||||
| Phase 4 | NCT05714176 | Feb 2023 → Jan 2024 | chronic kidney disease | Menoufia University | Unknown | No outcome recorded |
| Phase 4 | NCT05292001 | Jun 2022 → May 2026 overdue | anemia | Oregon Health and Science University | Recruiting | No outcome recorded |
| Phase 4 | NCT05047211 | Oct 2021 → Mar 2023 | iron deficiency anemia | The University of Texas Medical Branch, Galveston | Completed | No outcome recorded |
| Phase 4 | NCT03438227 | Apr 2018 → Dec 2019 | disorder of mineral absorption and transport, iron deficiency anemia | Indiana University | Completed | Met primary |
| Phase 4 | NCT02731378 | Dec 2016 → Apr 2019 | aregenerative anemia | Shanghai East Hospital | Unknown | No outcome recorded |
| Comparator or background therapy9 trials | ||||||
| Phase 2 | NCT07706582 Comparator | Nov 2025 → Sep 2026 overdue | end stage renal failure, iron deficiency anemia | Beni-Suef University | Active not recruiting | No outcome recorded |
| Phase 2 | NCT01307007 Comparator | Sep 2010 → May 2011 | iron deficiency anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01290315 Comparator | Aug 2009 → Mar 2013 | iron deficiency anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 2/3 | NCT01203514 Background | Aug 1997 → Aug 1998 | fetal growth restriction, neonatal anemia | NICHD Neonatal Research Network | Completed | Missed primary |
| Phase 3 | NCT00704353 Comparator | Jun 2008 → Jul 2009 | anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00704028 Comparator | Jun 2008 → Jan 2010 | anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 4 | NCT02086838 Comparator | Jul 2013 → Dec 2014 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT00593619 Comparator | Jan 2008 → Dec 2009 | iron deficiency anemia | London Health Sciences Centre | Suspended | No outcome recorded |
| — | NCT02889133 Comparator | Jan 2017 → Oct 2021 | disorder of iron metabolism and transport | Columbia University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 21 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iron Dextran | “Patients are randomised to receive either a single dose infusion of low-molecular weight iron dextran (1000 mg) or placebo (normal saline) postoperatively during their hospital...” PMID 36944463 ↗ Mar 202319“a weekly intravenous infusion of 5 mg/kg iron dextran until they had an enteral intake of 60 mL/kg/d” NCT01203514 ↗ “intravenous iron dextran” NCT07110935 ↗ |
| Known as | Dexferrum | “Ferrous Sulfate, Venofer, Ferrlecit, Infed, Dexferrum” NCT00704353 ↗ |
| Known as | infed | “Low molecular weight iron dextran (infed) 1000mg in sodium chloride 0.9% 500mL IV infusion over 1 hour preceded by test dose 25 mg IV low molecular weight iron dextran infusion...” NCT05047211 ↗2“single dose of 1000mg of low molecular weight iron dextran(infed).” NCT02038023 ↗ “Ferrous Sulfate, Venofer, Ferrlecit, Infed, Dexferrum” NCT00704353 ↗ |
| Known as | Iron Dextran(InFed) | “Iron Dextran(InFed)” NCT02038023 ↗ |
| Route | Intravenous | “Intravenous Iron Dextran Versus Iron Sucrose” NCT00593619 ↗ |